Monte Rosa Therapeutics | 8-K:重大事件
05/02 16:09 (美东)
Monte Rosa Therapeutics | 144:拟议出售证券
05/01 16:30 (美东)
Monte Rosa Therapeutics | DEFA14A:其他
04/26 16:44 (美东)
Monte Rosa Therapeutics | ARS:年度报告
04/26 16:34 (美东)
Monte Rosa Therapeutics | DEF 14A:股东委托书决议
04/26 16:05 (美东)
Monte Rosa Therapeutics | 144:拟议出售证券
04/10 16:29 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
04/10 13:02 (美东)
Monte Rosa Therapeutics | S-8:员工福利计划证券登记
03/14 16:11 (美东)
Monte Rosa Therapeutics | 10-K:年度报表
03/14 07:48 (美东)
Monte Rosa Therapeutics | 8-K:Monte Rosa Therapeutics公布2023年第四季度和全年财务业绩并提供公司最新情况
03/14 07:08 (美东)
Monte Rosa Therapeutics | SC 13G:超过5%持股股东披露文件-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%)等
02/14 17:46 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
02/14 15:09 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.7%)
02/14 11:27 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)
02/14 10:20 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(9.1%),Behzad Aghazadeh(9.1%)
02/14 09:17 (美东)
Monte Rosa Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(11.056%),Abigail P. Johnson(11.056%)
02/09 09:30 (美东)
Monte Rosa Therapeutics | 8-K:重大事件
01/08 00:00 (美东)
Monte Rosa Therapeutics | 4:持股变动声明-高管 Dunn Edmund
01/04 00:00 (美东)
Monte Rosa Therapeutics | 4:持股变动声明-高管 Wallace Owen B.
01/04 00:00 (美东)
Monte Rosa Therapeutics | 4:持股变动声明-高管 Warmuth Markus
01/04 00:00 (美东)
暂无数据
暂无数据